Nuvaxovid dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted)
- Licence status
- Active substances
- SARS-CoV-2 spike protein recombinant
- Dosage Form
- Dispersion for injection
- Licence number
- EU/1/21/1618/001
- Licence holder
- Sanofi Winthrop Industrie
Product documents
Licence information
- ATC code
- J07BN01 covid-19, RNA-based vaccine
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 20/12/2021